Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclooxygenase-2--10 years later.

Burkhard Hinz1, Kay Brune

  • 1Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany. hinz@pharmakologie.uni-erlangen.de

The Journal of Pharmacology and Experimental Therapeutics
|January 24, 2002
PubMed
Summary

Cyclooxygenase-2 (COX-2) inhibitors offer anti-inflammatory benefits by targeting COX-2, distinct from the housekeeping COX-1 enzyme. Recent research reveals COX-2

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cannabigerol and Cannabichromene Induce Lung Cancer Cell Death and Apoptosis-Contribution of PPARα to Cannabigerol Effects.

Antioxidants (Basel, Switzerland)·2026
Same author

Venetoclax and hypomethylating agents synergize to increase cell death and metabolic remodeling in acute B-lymphoblastic leukemia cells.

Molecular metabolism·2026
Same author

THC and CBD Induce Heme Oxygenase-1-Dependent Cell Death and Trigger Mitochondrial Dysfunction in Human Melanoma and Cutaneous Squamous Cell Carcinoma Cells.

Antioxidants (Basel, Switzerland)·2026
Same author

Schmerz (Berlin, Germany)·2025
Same author

In memory of Professor Dr. med. Dr. h. c. Kay Brune (1941-2025), Past President of the German Society for Experimental and Clinical Pharmacology and Toxicology and honorary member of the German Society for Pharmacology.

Naunyn-Schmiedeberg's archives of pharmacology·2025
Same author

CDK7 inhibition promotes glioblastoma cell death through convergent transcriptional and metabolic stress pathways.

Clinical and translational medicine·2025

Area of Science:

  • Biochemistry
  • Pharmacology
  • Immunology

Background:

  • Cyclooxygenase (COX) enzymes initiate prostanoid synthesis.
  • Two isoforms, COX-1 and COX-2, have been identified.
  • COX-1 is constitutively expressed, while COX-2 is inducible by inflammatory stimuli.

Purpose of the Study:

  • To review recent advances in cyclooxygenase-2 (COX-2) research.
  • To highlight new insights into the pathophysiological and physiological roles of COX-2.

Main Methods:

  • Literature review of recent studies on COX-2.
  • Assessment of COX-2's involvement in inflammation, pain, and physiological processes.

Main Results:

  • NSAID side effects are often linked to COX-1 inhibition.
  • COX-2 inhibition contributes to the therapeutic effects of NSAIDs.
  • Emerging evidence indicates COX-2 mediates various physiological functions beyond pathology.

Conclusions:

  • COX-2 specific inhibitors are valuable for pain and arthritis management.
  • COX-2's role extends to physiological processes, challenging its initial pathological focus.

Related Experiment Videos